Table 1.
Demographic and Pathological Data of 36 Patients with EOC
| Age, mean ± SD [range] | 62.8 ± 14.0; [27-87] |
|---|---|
| Ethnicity mother; n = 22 | |
| Jewish | 17 (77%) |
| Arab | 5 (23%) |
| BMI (n = 33), mean ± SD (range) | 27.8 ± 6.1; [18.3-42.2] |
| Parity | 2.83 ± 1.72; [0-8] |
| Comorbidities | |
| Hypertension | 14 (39%) |
| Diabetes | 7 (19%) |
| Dyslipidemia | 8 (22%) |
| Other | 22 (64%) |
| Primary site | |
| Ovary | 33 (91.6%) |
| Fallopian tube | 1 (2.77%) |
| Primary peritoneal | 3 (8.33%) |
| Unknown | 1 (2.77%) |
| Histology | |
| High-grade serous carcinoma | 29 (81%) |
| Low-grade serous carcinoma | 7 (19%) |
| Stage | |
| 1 | 8 (22%) |
| 2 | 2 (6%) |
| 3 | 15 (42%) |
| 4 | 11 (31%) |
| Other malignancy | |
| Breast | 2 (5.5%) |
| Lymphoma | 2 (5.5%) |
| None | 32 (89%) |
| Neoadjuvant chemotherapy | 17 (47.3%) |
| Primary surgery | 19 (52.7%) |